Australian Government - Department of Health

Medical Services Advisory Committee (MSAC)

1145 - Artificial Intervertebral Disc Replacement in Patients with Cervical Degenerative Disc Disease

MSAC ID

1145
Application NameArtificial Intervertebral Disc Replacement in Patients with Cervical Degenerative Disc Disease
Description of Medical ServiceThe proposed service is a surgical procedure for the implantation of a medical device used in the treatment and management of cervical DDD in patients who have failed to respond to conservative care. The procedure is known as CDA and involves surgical insertion of an artificial disc. Under general anaesthesia, the patient is placed in the supine position. The anterior cervical spine is exposed, and following standard discectomy and decompression of the neural elements, an artificial disc prosthesis is placed between the vertebrae.
Assessment TypeSubmission Based Assessment
Date Received by MSAC Secretariat3 February 2010
Stage 1 - Eligibility21 May 2010
Stage 2 - Assessment StatusAssessment Report - PDF Printable Version (PDF 461 KB)
Assessment Report Appendices - PDF Printable Version (PDF 1141 KB)
ESC considered this assessment on 12-13 October 2011.
MSAC appraised this assessment on 29 November 2011.
Public Summary Document - PDF Printable Version (PDF 187 KB)
Stage 3 - Formulation of Advice to the MinisterAfter considering the strength of the available evidence in relation to the safety, effectiveness and cost-effectiveness of artificial intervertebral disc replacement for dynamic stabilisation of the cervical spine (AIDR-C), MSAC supports public funding of AIDR-C for symptomatic single level cervical degenerative disc disease in skeletally mature patients with a mechanically stable cervical spine who have not responded to conservative therapy and who have not had prior cervical spine surgery.
Draft Item Descriptor:
Description Fee Benefit
CERVICAL ARTIFICIAL INTERVERTEBRAL TOTAL DISC REPLACEMENT
including removal of disc, 1 level only, in skeletally mature patients with single level cervical degenerative disc disease with radiculopathy in the absence of vertebral osteoporosis or prior spinal fusion at the same cervical level who have failed conservative therapy, with fluoroscopy
$1,023.25 75% = $767.44
Stage 4 - Noting by Minister:
  • advice is not communicated to the Minister until the Minutes of the relevant meeting have been ratified by MSAC members (which may take several weeks)
  • the Minister needs time to properly consider MSAC's advice (and may choose to seek further policy advice from the department before noting the advice)
  • a Government decision to list a service supported by MSAC is taken in the context of other Government priorities: MSAC's support of an application for public funding does not oblige the Government to list the service on the MBS
The Minister noted MSAC's advice 12 June 2012.
Stage 5 - Implementation1 November 2012
MBS item number 48694.